Posted on April 27th, 2015
John M. Holliman, III has served as Executive Chairman and Principal Executive Officer of the Company since April 2006.
Company OverviewEffective October 1, 2008, OrthoLogic Corp. began doing business as Capstone Therapeutics (the "Company") (OTCQB: CAPS); on May 21, 2010 the name of the Company was changed from OrthoLogic Corp. to Capstone Therapeutics Corp. Capstone Therapeutics Corp. is a biotechnology company committed to developing a pipeline of novel peptides and other molecules aimed at helping patients with under-served medical conditions. Previously, we were focused on the development and commercialization of two product platforms: AZX100 and Chrysalin (TP508). We no longer have any interest in or rights to Chrysalin. On August 3, 2012, we entered into a joint venture, LipimetiX Development, LLC, (the “JV”) to develop Apo E mimetic peptide molecule AEM-28 and its analogs. In 2012 we wound down internal operations, ceased clinical development of AZX100 in dermal scarring, formerly our principal drug candidate, and moved to a mor... Learn More »
Capstone Therapeutics Corp. and its joint development partner, LipimetiX Development, LLC, reported data from its Phase ...Read More »
Posted on April 24th, 2015
With the Bio Asia meeting in perspective, I can say that the time spent there was as promising as I had hoped and the ta...Read More »
Posted on April 21st, 2015
“Developing drugs for rare diseases starting with conditions that affect the kidneys.” You can find this statement...Read More »
Posted on April 7th, 2015
“It was the best of times, it was the worst of times, it was the age of wisdom, it was the age of foolishness…” A ...Read More »
Posted on March 26th, 2015
The goal of my blog posting today is to provide an overview of the status of our Diagnostics and Therapeutics business u...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »